StockPriceToday
Calamos Dynamic Convertible & Income Fund (CCD)
About Calamos Dynamic Convertible & Income Fund
Calamos Dynamic Convertible & Income Fund operates as a closed-end management investment company focused on investing in convertible securities and other income-producing investments to provide total return through capital appreciation and income generation. The fund's investment focus makes CCD stock price sensitive to convertible bond market conditions, interest rate changes, and equity market volatility.
The fund's investment strategy emphasizes convertible bonds, preferred stocks, and other hybrid securities that provide both income generation and equity upside participation potential. CCD's portfolio management approach seeks to optimize risk-adjusted returns through active security selection and portfolio construction.
CCD stock price typically reflects both the underlying portfolio performance and closed-end fund market dynamics including premium or discount to net asset value. The fund's focus on convertible securities provides exposure to both fixed income and equity characteristics.
Calamos Dynamic Convertible & Income Fund's specialized expertise in convertible securities and income investing positions the fund to serve investors seeking balanced exposure to fixed income and equity markets. The fund's active management approach and convertible security focus support CCD stock price potential for investors seeking diversified income and growth opportunities.
CCD Stock 12 Month Chart
Latest News for CCD
For the quarter ending June 30, 2025, Calamos Dynamic Convertible And Income Fund rose 14.15% on NAV but declined -2.53% on price. Current annualized distribution rate is the Fund’s most recent ...
Other Popular Stocks
Qualys Inc. (QLYS) is a pioneer and leading provider of cloud-based security and compliance solutions, offering vulnerability management, threat detection, and compliance monitoring through...
Day One Biopharmaceuticals Inc. (DAWN) is a clinical-stage biopharmaceutical company focused on developing targeted therapies for patients with life-threatening diseases, particularly pediatric cancers.
BOK Financial Corporation operates as a bank holding company providing commercial and retail banking services in multiple states.